IntraBio says rare disease drug passes Phase 3, will seek FDA approvalnews2026-01-21T16:05:26+00:00January 21st, 2026|Endpoints News|
#JPM26: Regeneron, Lilly, Summit on rivals crowding into same targetsnews2026-01-21T14:00:49+00:00January 21st, 2026|Endpoints News|
Exclusive: Claim Health raises $4.4M to help home care providers get paidnews2026-01-21T14:00:46+00:00January 21st, 2026|Endpoints News|
Fosun-funded Hygtia Therapeutics licenses Insilico’s NLRP3 inhibitor for Parkinson’snews2026-01-21T12:14:26+00:00January 21st, 2026|Endpoints News|
Think Bioscience gets $55M to unearth new drug pocketsnews2026-01-21T12:00:50+00:00January 21st, 2026|Endpoints News|
Government funding bill features PBM reforms, voucher reauthorizationnews2026-01-20T19:14:42+00:00January 20th, 2026|Endpoints News|
EU Parliament adopts stricter drug stockpiling rules under Critical Medicines Actnews2026-01-20T18:55:38+00:00January 20th, 2026|Endpoints News|
Valneva withdraws chikungunya vaccine from USnews2026-01-20T18:37:12+00:00January 20th, 2026|Endpoints News|
Clinician groups ask court to overturn CDC’s childhood vaccine overhaulnews2026-01-20T15:54:25+00:00January 20th, 2026|Endpoints News|
Aspect Bio takes Novo castoff therapies; Takeda trims US jobsnews2026-01-20T14:58:33+00:00January 20th, 2026|Endpoints News|
